Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease : Results from the MOPEAD project
-
Boada, Mercè (Universitat Internacional de Catalunya)
;
Rodrigo, Adrián (GMV SECURE E SOLUTIONS) ;
Jessen, Frank (Uniklinik Köln (Colònia, Alemanya)) ;
Wimblad, Bengt (Karolinska Univ Hospital) ;
Kramberger, Milica G. (Univerza V Ljubljani) ;
Visser, Pieter Jelle (Maastricht University) ;
Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron) ;
Rodríguez-Gomez, Octavio (Universitat Internacional de Catalunya) ;
Ciudin, Andreea (Hospital Universitari Vall d'Hebron) ;
Georges, Jean (Alzheimer Europe) ;
Dumas, Annete (ASDM Consulting) ;
Maguire, Peggy (European Institute of Women's Health) ;
Krivec, David (Zdruzenje Spomincica) ;
Wimo, Anders (Karolinska Institutet (Estocolm, Suècia)) ;
Valero, Sergi (Instituto de Salud Carlos III) ;
Alegret, Montserrat (Instituto de Salud Carlos III) ;
Jamilis, Laura (GMV SECURE E SOLUTIONS) ;
Zwan, Marissa (Vrije Universiteit Amsterdam) ;
Sannemann, Lena (Uniklinik Köln (Colònia, Alemanya)) ;
Arrufat, Jordi (EAP Sarrià-Vallvidrera-Les Planes) ;
Stomrud, Erik (Region Kalmar County) ;
Johansson, Gunilla (Karolinska Institutet (Estocolm, Suècia)) ;
Glaysher, Bridget (Modus Research and Innovation Limited) ;
Stewart, Neil (Modus Research and Innovation Limited) ;
Belger, Mark (Eli Lilly and Company (Lilly UK)) ;
Iradier, Fatima (Eli Lilly and Company) ;
Campo, Laura (Eli Lilly and Company) ;
Universitat Autònoma de Barcelona
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
